Development of Camera Based Gait Quality Measure for Persons With Multiple Sclerosis

Description

The purpose of this study is to develop a measurement of walking quality, called Gait Deviation Index (GDI) for people with Multiple Sclerosis (MS).

Conditions

Multiple Sclerosis, Multiple Sclerosis, Secondary Progressive, Multiple Sclerosis Relapse, Multiple Sclerosis, Relapsing-Remitting

Talk to us

Study Overview

On this page

Study Details

Study overview

The purpose of this study is to develop a measurement of walking quality, called Gait Deviation Index (GDI) for people with Multiple Sclerosis (MS).

Development of Camera Based Gait Deviation Index for Persons With Multiple Sclerosis

Development of Camera Based Gait Quality Measure for Persons With Multiple Sclerosis

Condition
Multiple Sclerosis
Intervention / Treatment

-

Contacts and Locations

Chicago

Shirley Ryan AbilityLab, Chicago, Illinois, United States, 60611

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Diagnosis of relapsing form of MS (including relapsing-remitting MS and secondary progressive MS)
  • * Able to ambulate overground
  • * Relapse free for at least 1 month
  • * Age ≥18 and ≤ 75 years
  • * Participants using dalfampridine will be eligible if taking the same daily dose for at least 2 months prior to screening

Ages Eligible for Study

18 Years to 75 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Shirley Ryan AbilityLab,

Milap Sandhu, PhD, PRINCIPAL_INVESTIGATOR, Shirley Ryan AbilityLab

Study Record Dates

2026-07